FOXNews.com: FDA extends review time for bowel drug

FOXNews.com FOX News Network - We Report. You Decide.

FDA extends review time for bowel drug Aug 14th 2012, 11:31 Santarus Inc said U.S. health regulators extended the action date on its experimental bowel disease drug by three months, sending its shares down as much as 8 percent in extended trade

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions